Gotowe bibliografie tematyczne / Congestive heart disease

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Congestive heart disease”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Congestive heart disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Congestive heart disease"

1

Fortea, José Ignacio, Ángela Puente, Antonio Cuadrado, et al. "Congestive Hepatopathy." International Journal of Molecular Sciences 21, no. 24 (2020): 9420. http://dx.doi.org/10.3390/ijms21249420.

Pełny tekst źródła
Streszczenie:
Liver disease resulting from heart failure (HF) has generally been referred as “cardiac hepatopathy”. One of its main forms is congestive hepatopathy (CH), which results from passive venous congestion in the setting of chronic right-sided HF. The current spectrum of CH differs from earlier reports with HF, due to ischemic cardiomyopathy and congenital heart disease having surpassed rheumatic valvular disease. The chronic passive congestion leads to sinusoidal hypertension, centrilobular fibrosis, and ultimately, cirrhosis (“cardiac cirrhosis”) and hepatocellular carcinoma after several decades
Style APA, Harvard, Vancouver, ISO itp.
2

Muqeem, Hina, BD Khan, Mohd Mohsin, and Mohd Nazir Mannan. "Congestive Heart Failure in the Light of Ancient Wisdom of Unani Medicine: A Review." Journal of Phytopharmacology 12, no. 5 (2023): 334–40. http://dx.doi.org/10.31254/phyto.2023.12509.

Pełny tekst źródła
Streszczenie:
Congestive heart failure is a complex clinical syndrome that causes functional impairment of ventricular filling and ejection of blood. It can cause dyspnea, fatigue, and fluid retention, affecting exercise tolerance and causing pulmonary and peripheral edema. Moreover, it is a burgeoning and life-threatening syndrome characterized by significant morbidity and mortality, poor functional capacity and quality of life, and high costs. Worldwide congestive heart failure affects more than 64 million people. Nowadays: congestive heart failure is correlated with Suqūṭ-e-Qalb Imtilāʼī, by modern Unani
Style APA, Harvard, Vancouver, ISO itp.
3

Kishanrao, Suresh. "Congestive Heart Failure in Indian Elders." Clinical Cardiovascular Research 2, no. 1 (2023): 01–04. http://dx.doi.org/10.58489/2836-5917/006.

Pełny tekst źródła
Streszczenie:
Congestive Heart Failure (CHF) is a common complex clinical syndrome that underlines the inability of the heart to perform its circulatory function with the desired efficiency due to structural and/or functional alterations. There is paucity of good and reliable data in India and many developing countries on heart failure. The management of heart failurehas evolved over the years with the advent of new drugs and devices.But there is a need to uneartha true and meaningful nationaldata on the risk factors,available treatment options,and challenges in management that could be addressed to take ad
Style APA, Harvard, Vancouver, ISO itp.
4

Tavel, Morton E., Jeffrey A. Breall, and Bernard J. Gersh. "Ischemic Heart Disease With Congestive Heart Failure." Chest 113, no. 4 (1998): 1119–22. http://dx.doi.org/10.1378/chest.113.4.1119.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.178-187.

Pełny tekst źródła
Streszczenie:
Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequen
Style APA, Harvard, Vancouver, ISO itp.
6

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.34-43.

Pełny tekst źródła
Streszczenie:
Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequen
Style APA, Harvard, Vancouver, ISO itp.
7

Emanuelsson, H. "CONGESTIVE HEART FAILURE SECONDARY TO ISCHEMIC HEART DISEASE." Acta Medica Scandinavica 220, S712 (2009): 65–71. http://dx.doi.org/10.1111/j.0954-6820.1986.tb13959.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Polidori, M. Cristina, Elena Mariani, Patrizia Mecocci, and Gereon Nelles. "Congestive heart failure and Alzheimer's disease." Neurological Research 28, no. 6 (2006): 588–94. http://dx.doi.org/10.1179/016164106x130489.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Dolan, Justin, Stacy Mandras, Jinesh P. Mehta, et al. "Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management." Pulmonary Circulation 10, no. 4 (2020): 204589402096847. http://dx.doi.org/10.1177/2045894020968471.

Pełny tekst źródła
Streszczenie:
Pulmonary hypertension currently has minimal guidelines for outpatient disease management. Congestive heart failure studies, however, have shown effectiveness of disease management plans in reducing all-cause mortality and all-cause and congestive heart failure-related hospital readmissions. Heart failure exacerbation is a common reason for readmission in both pulmonary hypertension and congestive heart failure. Our aim was to review individual studies and comprehensive meta-analyses to identify effective congestive heart failure interventions that can be used to develop similar disease manage
Style APA, Harvard, Vancouver, ISO itp.
10

Di Lullo, Luca, Antonio Bellasi, Domenico Russo, et al. "Ivabradine, Heart Failure and Chronic Kidney Disease." Nephrology @ Point of Care 1, no. 1 (2015): poc.5000190. http://dx.doi.org/10.5301/poc.5000190.

Pełny tekst źródła
Streszczenie:
The incidence and prevalence of congestive heart failure are actually increasing worldwide, especially in Western countries. In Europe and the United States, congestive heart failure represents a disabling clinical disease, accountable for increased hospitalization and health care costs. European guidelines have underlined the importance of pharmacological treatment to improve both patients' outcomes and quality of life. The latest clinical trials to evaluate ivabradine's efficacy have underlined its usefulness as a stand-alone medication and in combination with conventional congestive heart f
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Congestive heart disease"

1

Kadri, Amer N., Vivek Menon, Yasser M. Sammour, et al. "Outcomes of patients with severe tricuspid regurgitation and congestive heart failure." BMJ Publishing Group, 2019. http://hdl.handle.net/10757/652470.

Pełny tekst źródła
Streszczenie:
Objectives A substantial number of patients with severe tricuspid regurgitation (TR) and congestive heart failure (CHF) are medically managed without undergoing corrective surgery. We sought to assess the characteristics and outcomes of CHF patients who underwent tricuspid valve surgery (TVS), compared with those who did not. Methods Retrospective observational study involving 2556 consecutive patients with severe TR from the Cleveland Clinic Echocardiographic Database. Cardiac transplant patients or those without CHF were excluded. Survival difference between patients who were medically manag
Style APA, Harvard, Vancouver, ISO itp.
2

Chen, Jye-Daa. "Theophylline disposition in patients with hepatic disease and congestive heart failure." Scholarly Commons, 1992. https://scholarlycommons.pacific.edu/uop_etds/2239.

Pełny tekst źródła
Streszczenie:
The theophylline clearance was evaluated in patients with liver dysfunction and/or congestive heart failure. One hundred and twenty two patients were categorized into four groups; Group I: Liver dysfunction (n=20), Group II: Congestive heart failure (CHF, n=22), Group III: Both liver dysfunction and CHF (n=12), and Group IV: Control group (n=68). The severity of liver dysfunction and CHF were evaluated using Child-Turcotte- Pugh index (CTP) and a Cardiac Function index, respectively. Theophylline clearance was significantly decreased in Groups I, II, and III when compared to the control group;
Style APA, Harvard, Vancouver, ISO itp.
3

Sartipy, Ulrik. "Left ventricular reconstruction in ischemic heart disease /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-028-2/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Fang, Zhi You. "Mechanisms and therapeutic implications of diabetic heart disease /." [St. Lucia, Qld], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18240.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Stewart, Simon. "Optimising therapeutic efficacy in acute and chronic cardiac disease states /." Title page, contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phs851.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Korpon, Mary Lou. "Positioning and physiologic changes during feeding of infants with congestive heart failure secondary to congenital heart disease." Thesis, The University of Arizona, 1988. http://hdl.handle.net/10150/276769.

Pełny tekst źródła
Streszczenie:
A descriptive design was used in this study to describe the feeding behaviors (as defined by changes in body position) in infants with congestive heart failure secondary to congenital heart disease. In addition, short term physiologic changes associated with the behaviors were measured through the use of pulse oximetry and cardiorespiratory monitors. Nine infants were observed in this study as they were being fed by their nurses. The method chosen was naturalistic observation. Descriptive statistics were used to analyze the demographic data and the measured physiologic variables. A point by se
Style APA, Harvard, Vancouver, ISO itp.
7

Yata, Mariko. "Novel approaches to management of congestive heart failure in dogs and cats." Thesis, The University of Sydney, 2018. http://hdl.handle.net/2123/19617.

Pełny tekst źródła
Streszczenie:
Congestive heart failure (CHF) is the most commonly treated condition in veterinary cardiology as it is the sequela of a multitude of cardiovascular diseases. This thesis reviews current practices in veterinary CHF therapeutics and explores novel approaches to therapy through examining three aspects of this topic: the differences in pimobendan pharmacokinetics and pharmacodynamics between dogs and cats; the role of multi-modal therapy in dogs with CHF; and the role of the brain natriuretic peptide (BNP) system in dogs with CHF. Pimobendan metabolism and treatment effects were reduced in cats c
Style APA, Harvard, Vancouver, ISO itp.
8

Butt, Muhammad U. "AGGRESSIVE DIURESIS AND SEVERITY-ADJUSTED LENGTH OF HOSPITAL STAY IN ACUTE CONGESTIVE HEART FAILURE PATIENTS." UKnowledge, 2018. https://uknowledge.uky.edu/crd_etds/2.

Pełny tekst źródła
Streszczenie:
To see if aggressive diuresis in first twenty four hours is associated with a comparable number of total days in the hospital as compared to non-aggressive diuresis. In this retrospective cohort study, we compared the length of hospital stay of consecutive patients admitted in one year based on their diuresis during the first twenty-four hours of hospitalization: aggressive diuresis (group 1) i.e. > 2400mL versus non-aggressive diuresis (group 2) i.e. ≤ 2400mL urine output. Patients were excluded if in cardiogenic shock, had creatinine level above 3 mg/dL on admission, or on dialysis. A total
Style APA, Harvard, Vancouver, ISO itp.
9

Kjellström, Barbro. "The usefulness of continuous hemodynamic monitoring to guide therapy in patients with cardiopulmonary disease /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-225-5/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Pelegrino, Viviane Martinelli. "Avaliação do estado de saúde percebido e do impacto da insuficiência cardíaca por pacientes em seguimento ambulatorial." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/22/22132/tde-27052008-144220/.

Pełny tekst źródła
Streszczenie:
A Insuficiência Cardíaca (IC) é uma doença crônica e incapacitante de alta morbi-mortalidade que provoca mudanças na qualidade de vida relacionadas à saúde (QVRS). Foi realizado um estudo descritivo, correlacional tipo corte transversal com 138 pacientes com IC em seguimento ambulatorial com os objetivos de avaliar: o estado geral de saúde por meio do Medical Outcomes Survey 36 - Item Short-Form (SF-36), o impacto da IC na vida diária utilizando o Minnesota Living with Heart Failure Questionnaire (MLHFQ) e analisar as relações entre essas duas variáveis e do estado de saúde percebido e do impa
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Congestive heart disease"

1

Kereiakes, Dean J. Heart disease: What you should know. 2nd ed. Blackwell Science, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Swynghedauw, B. L' insuffisance cardiaque chronique de l'adulte. Ellipses, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sauberman, Roy B. A Prospective, double-blind, randomized, placebo-controlled study to evaluate the effects of felodipine in patients with ischemic cardiomyopathy and congestive heart failure already receiving maximal medical therapy. s.n.], 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Böhm, M. Chronic heart failure. Springer, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

H, Lorell Beverly, Grossman William 1940-, and International Symposium on the Biology of Diastole in Health and Disease (1993 : Palm Beach, Fla.), eds. Diastolic relaxation of the heart: The biology of diastole in health and disease. 2nd ed. Kluwer Academic Publishers, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

1958-, Böhm M., and Laragh John H. 1924-, eds. From hypertension to heart failure. Springer, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

L, Pearson Marjorie, and National Institute of Nursing Research (U.S.), eds. An Implicit review method for measuring the quality of in-hospital nursing care of elderly congestive heart failure patients. RAND, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Cheuk-Man, Yu, Hayes David L, and Auricchio Angelo, eds. Cardiac resynchronization therapy. Blackwell Pub., 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

B, Wu Alan H., ed. Cardiac markers. 2nd ed. Humana Press, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

C, Fang James, and Couper Gregory S, eds. Surgical management of congestive heart failure. Humana Press, 2005.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Congestive heart disease"

1

O’Connell, John B., and Jay W. Mason. "Inflammatory Heart Disease." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_14.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Olsen, E. G. J., and R. O. Brandenburg. "Dilated (Congestive) Cardiomyopathy." In Heart Muscle Disease. Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-009-4874-7_3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Morton, Mark J. "Heart Failure Secondary to Congenital Heart Disease." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Fowler, Noble O. "Congestive Heart Failure." In Diagnosis of Heart Disease. Springer New York, 1991. http://dx.doi.org/10.1007/978-1-4612-3068-7_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Mills, Roger M., and Carl J. Pepine. "Heart Failure Secondary to Coronary Artery Disease." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Greenberg, Barry H. "Congestive Heart Failure as a Consequence of Valvular Heart Disease." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Kalmar, Jayne M., Brigid M. Lynch, Christine M. Friedenreich, et al. "Congestive Heart Failure." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2248.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Friedewald, Vincent E. "Heart Failure (CHF/Congestive Heart Failure)." In Clinical Guide to Cardiovascular Disease. Springer London, 2016. http://dx.doi.org/10.1007/978-1-4471-7293-2_52.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wilensky, Robert L., and Bruce D. Klugherz. "Coronary Artery Disease and Congestive Heart Failure." In Heart Failure. Humana Press, 2003. https://doi.org/10.1007/978-1-59259-347-7_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Hamer, John. "Vasodilator therapy in congestive heart failure." In Drugs for Heart Disease. Springer US, 1987. http://dx.doi.org/10.1007/978-1-4899-3294-5_9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Congestive heart disease"

1

Batavani, Nafiseh, and Mohammad Reza Yousefi. "Classification of Congestive Heart Failure Disease, Arrhythmias, And Normal Heart Rhythms Using Deep Learning." In 2024 11th International Symposium on Telecommunications (IST). IEEE, 2024. https://doi.org/10.1109/ist64061.2024.10843440.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Xiao, Min, Annie Bailey, and Olga Pierrakos. "In-Vitro Modeling of Heart Failure in the Presence of a Prosthetic Heart Valve Using Particle Image Velocimetry." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53788.

Pełny tekst źródła
Streszczenie:
It is well-known that cardiovascular disease, affecting millions of people, is the number one killer in the US and worldwide. Current trends indicate that cardiovascular disease (CVD) will claim approximately 20 million victims in 2020 as the leading cause of death worldwide and will be responsible for over a billion deaths between 2000 and 2050 [1]. According to the American Heart Association, one in three American adults have one or more types of heart disease. Economically, the total and indirect costs due to cardiovascular diseases in 2009 were estimated at $475.3 billion. The spectrum of
Style APA, Harvard, Vancouver, ISO itp.
3

Ulerich, Joseph P., Serdar Goktepe, and Ellen Kuhl. "First Attempts Towards the Computational Simulation of Novel Stem-Cell Based Post Infarct Therapies." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192715.

Pełny tekst źródła
Streszczenie:
Cardiac disease is the most common cause of death in developed nations and affects more than 80 million American adults every year. Among cardiac diseases, myocardial infarction is one of the leading causes of congestive heart failure. Due to an infarct, the loads within the heart alter and within hours a remodeling process begins as the heart attempts to optimize function given its diminished capacity. This remodeling process itself can cause inconsistent thinning and dilation leading to potential problems such as volume overloaded hypertrophy and often causes further functional deterioration
Style APA, Harvard, Vancouver, ISO itp.
4

Mesihović-Dinarević, Senka. "WHAT IS NEW IN CARDIOVASCULAR MEDICINE?" In Symposium with International Participation HEART AND … Akademija nauka i umjetnosti Bosne i Hercegovine, 2019. http://dx.doi.org/10.5644/pi2019.181.03.

Pełny tekst źródła
Streszczenie:
The rapid pace of change continues to be a hallmark in cardiovascular medicine and many see that pace accelerating in adult cardiovascular medicine as well as in paediatric cardiology medicine. Cardiovascular medicine is an area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology. Cardiovascular diseases are the leading cause of mortality in the world and cause major costs for the health sector and economy. Primary care clinicians are challenged to optimally manage a multitude of diseases including congestive heart failure, corona
Style APA, Harvard, Vancouver, ISO itp.
5

Carvalho, AC, LF Drager, PR Genta, et al. "Comparison of Sleep Apnea in Patients with Valve Disease Versus Congestive Heart Failure." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5330.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Jiang, A. A., M. M. Nobari, J. Boys, R. J. Miller, and G. Z. Cheng. "Refractory Pleural Effusions Secondary to Grave's Disease Without Evidence of Congestive Heart Failure." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1935.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Besfat, Henok Mezemr, Demissie Jobir Gelmecha, Ram Sewak Singh, et al. "Spectral Analysis of Congestive Heart Failure Cardiac Disease using Flexible Analytic Wavelet Transform." In 2024 11th International Conference on Computing for Sustainable Global Development (INDIACom). IEEE, 2024. http://dx.doi.org/10.23919/indiacom61295.2024.10498656.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Tancredi, M., E. Cendrowski, N. Balasubramanian, C. Joyce, and M. Afshar. "Natural Language Processing to Identify Cases of Chronic Obstructive Pulmonary Disease or Congestive Heart Failure." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5109.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Saint-Pierre, M. D., J. Abdulnour, and R. Sabbagh. "Interstitial Lung Disease and Congestive Heart Failure Overlap: Impact of this Presentation on Hospitalization Rates." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1587.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Gross, Katherine, Thomas Waring, Harsh Chawla, Chinthaka Bulathsinghala, Richard Soucier, and Richard ZuWallack. "Physical activity after discharge following chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) exacerbations." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa3549.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Congestive heart disease"

1

Towne Jr, Samuel D., Timothy H. Callaghan, Alva O. Ferdinand, Marvellous Akinlotan, Kristin Primm, and Jane Bolin. Prevalence and Mortality of Heart Disease and Related Conditions: Disparities affecting the South, Rural Areas, and American India, and Alaska Natives. Southwest Rural Health Research Center, Texas A&M School of Public Health, 2019. http://dx.doi.org/10.21423/1969.1/201262.

Pełny tekst źródła
Streszczenie:
Across the U.S., major health inequities persist across several social and structural determinants of health. In this brief, we explored the intersection of these social and structural determinants across major diseases and disease-related mortality. The likelihood of stroke, angina or coronary heart disease, and heart attack (myocardial infarction) was significantly higher in the South and for American Indian or Alaska Native individuals as compared to White individuals. Rural areas of the South experienced high rates of mortality for multiple years related to congestive heart failure, ischem
Style APA, Harvard, Vancouver, ISO itp.
2

Husidic, Dejvid. The Effect of SGLT-2 Inhibitors in Non-Diabetic Patients with Diseases Such as Congestive Heart Failure and Chronic Kidney Disease. Iowa State University, 2022. http://dx.doi.org/10.31274/cc-20240624-1425.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Congestive heart disease” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii